Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.5 million people in 2020, TB is the world’s second deadliest infectious disease after COVID-19 (WHO).

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic.

Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB (DR-TB). But the harsh reality remains - 10 million people fell sick with TB in 2020 and nearly half a million developed DR-TB, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2020. The majority go undiagnosed and therefore untreated.

IN 2021

Quick facts about Tuberculosis

A picture of the road leading to the village Vuma in Mbongolwane, KZN

Eshowe project closure – the power of partnerships

Press Release 5 Dec 2023
MSF,  endTB clinical trial results.

TB: Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Press Release 15 Nov 2023
MSF, BPaLM regimens - DR-TB Treatment, WHO TB Report 2023

WHO’s Annual Global TB Report

Press Release 7 Nov 2023

MSF responds to Johnson & Johnson not enforcing patents on key TB drug bedaquiline

Press Release 2 Oct 2023
MSF, Drug-resistant Tuberculosis Treatment

Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests

Press Release 13 Sep 2023
MSF, Doctors Without Borders, TB

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Press Release 14 Jul 2023